Center for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, 11 Bei San Huan Dong Lu, Chaoyang District, Beijing 100029, China.
Center for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, 11 Bei San Huan Dong Lu, Chaoyang District, Beijing 100029, China ; NAFKAM, University of Tromso, Tromso, NO-9037, Norway.
Evid Based Complement Alternat Med. 2013;2013:362831. doi: 10.1155/2013/362831. Epub 2013 Dec 17.
Background. Acupoint stimulation is popular for treatment of fibromyalgia though there is lack of comprehensive evaluation of current clinical evidence for its effect and safety. Objective. To systematically review the beneficial effects and safety of acupoint stimulation for fibromyalgia. Methods. We searched six electronic databases for randomized trials on acupoint stimulation for treatment of fibromyalgia. Two authors extracted data and assessed the trial quality independently. RevMan 5.2 software was used for data analyses with effect estimate presented as (standard) mean difference and a 95% confidence interval. We defined minimum, medium, and large SMD effect sizes as 0.3, 0.5, and 0.75. Results. 16 RCTs with 1081 participants were involved in this review. Only two trials were evaluated as low risk of bias. Meta-analysis showed that acupuncture alone or combined with cupping therapy was superior to conventional medications on reducing pain scores and/or the number of tender points. However, acupuncture showed no better than sham acupuncture on pain reduction. There was no serious adverse event reported to be related to acupoint stimulation. Conclusions. Acupoint stimulation appears to be effective in treating fibromyalgia compared with medications. However, further large, rigorously designed trials are warranted due to insufficient methodological rigor in the included trials.
穴位刺激在治疗纤维肌痛症方面很受欢迎,但目前缺乏对其疗效和安全性的全面评估。
系统评价穴位刺激治疗纤维肌痛症的有益效果和安全性。
我们检索了六个电子数据库,以获取穴位刺激治疗纤维肌痛症的随机试验。两位作者独立提取数据并评估试验质量。RevMan 5.2 软件用于数据分析,效应估计表示为(标准)均数差和 95%置信区间。我们将最小、中、大 SMD 效应大小定义为 0.3、0.5 和 0.75。
本综述纳入了 16 项 RCT 共 1081 名参与者。只有两项试验被评估为低偏倚风险。荟萃分析表明,单独针刺或结合拔罐疗法在减轻疼痛评分和/或压痛点数方面优于常规药物治疗。然而,针刺在减轻疼痛方面并不优于假针刺。没有报道与穴位刺激相关的严重不良事件。
与药物治疗相比,穴位刺激似乎对纤维肌痛症有效。但是,由于纳入试验的方法学严谨性不足,需要进一步进行大型、严谨设计的试验。